Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Feja, M.
Lang, M.
Deppermann, L.
Yüksel, A.
and
Wischhof, L.
2015.
High levels of impulsivity in rats are not accompanied by sensorimotor gating deficits and locomotor hyperactivity.
Behavioural Processes,
Vol. 121,
Issue. ,
p.
13.
Paris, Jason J.
Singh, Harminder D.
Carey, Amanda N.
and
McLaughlin, Jay P.
2015.
Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.
Behavioural Brain Research,
Vol. 291,
Issue. ,
p.
209.
Vigorito, Michael
Connaghan, Kaitlyn P.
and
Chang, Sulie L.
2015.
The HIV-1 transgenic rat model of neuroHIV.
Brain, Behavior, and Immunity,
Vol. 48,
Issue. ,
p.
336.
Soontornniyomkij, Virawudh
Kesby, James P.
Morgan, Erin E.
Bischoff-Grethe, Amanda
Minassian, Arpi
Brown, Gregory G.
and
Grant, Igor
2016.
Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.
Journal of Neuroimmune Pharmacology,
Vol. 11,
Issue. 3,
p.
495.
Bachis, Alessia
Forcelli, Patrick
Masliah, Eliezer
Campbell, Lee
and
Mocchetti, Italo
2016.
Expression of gp120 in mice evokes anxiety behavior: Co-occurrence with increased dendritic spines and brain-derived neurotrophic factor in the amygdala.
Brain, Behavior, and Immunity,
Vol. 54,
Issue. ,
p.
170.
McLaurin, Kristen A.
Booze, Rosemarie M.
and
Mactutus, Charles F.
2016.
Progression of temporal processing deficits in the HIV-1 transgenic rat.
Scientific Reports,
Vol. 6,
Issue. 1,
Gaskill, Peter J.
Miller, Douglas R.
Gamble-George, Joyonna
Yano, Hideaki
and
Khoshbouei, Habibeh
2017.
HIV, Tat and dopamine transmission.
Neurobiology of Disease,
Vol. 105,
Issue. ,
p.
51.
McLaurin, Kristen A.
Booze, Rosemarie M.
and
Mactutus, Charles F.
2017.
Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1.
Journal of NeuroVirology,
Vol. 23,
Issue. 1,
p.
87.
McLaurin, Kristen A.
Booze, Rosemarie M.
and
Mactutus, Charles F.
2017.
Temporal processsing demands in the HIV‐1 transgenic rat: Amodal gating and implications for diagnostics.
International Journal of Developmental Neuroscience,
Vol. 57,
Issue. 1,
p.
12.
McLaurin, Kristen A.
Moran, Landhing M.
Li, Hailong
Booze, Rosemarie M.
and
Mactutus, Charles F.
2017.
A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat.
Journal of Neuroimmune Pharmacology,
Vol. 12,
Issue. 1,
p.
171.
Thaney, Victoria E.
Sanchez, Ana B.
Fields, Jerel A.
Minassian, Arpi
Young, Jared W.
Maung, Ricky
and
Kaul, Marcus
2018.
Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.
Journal of NeuroVirology,
Vol. 24,
Issue. 2,
p.
156.
Fitting, Sylvia
McLaurin, Kristen A.
Booze, Rosemarie M.
and
Mactutus, Charles F.
2018.
Dose‐dependent neurocognitive deficits following postnatal day 10 HIV‐1 viral protein exposure: Relationship to hippocampal anatomy parameters.
International Journal of Developmental Neuroscience,
Vol. 65,
Issue. 1,
p.
66.
McLaurin, Kristen A.
Mactutus, Charles F.
Booze, Rosemarie M.
and
Fairchild, Amanda J.
2019.
An Empirical Mediation Analysis of Mechanisms Underlying HIV-1-Associated Neurocognitive Disorders.
Brain Research,
Vol. 1724,
Issue. ,
p.
146436.
McLaurin, Kristen A.
Booze, Rosemarie M.
and
Mactutus, Charles F.
2019.
Diagnostic and prognostic biomarkers for HAND.
Journal of NeuroVirology,
Vol. 25,
Issue. 5,
p.
686.
McLaurin, Kristen A.
Moran, Landhing M.
Booze, Rosemarie M.
and
Mactutus, Charles F.
2020.
Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders.
Journal of Neuroimmune Pharmacology,
Vol. 15,
Issue. 2,
p.
264.
Saloner, Rowan
Fields, Jerel Adam
Marcondes, Maria Cecilia Garibaldi
Iudicello, Jennifer E.
von Känel, Sofie
Cherner, Mariana
Letendre, Scott L.
Kaul, Marcus
and
Grant, Igor
2020.
Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.
Journal of Neuroimmune Pharmacology,
Vol. 15,
Issue. 4,
p.
743.
Lee, Jared
Lee, Ji-Young
Meade, Christina S.
Cohn, Michael
Chahine, Antonio
Dilworth, Samantha E.
Magidson, Jessica F.
Gouse, Hetta
Fuchs, Dietmar
and
Carrico, Adam W.
2020.
Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection.
Journal of NeuroVirology,
Vol. 26,
Issue. 5,
p.
779.
Li, Hailong
McLaurin, Kristen
Illenberger, Jessica
Mactutus, Charles
and
Booze, Rosemarie
2021.
Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders.
Viruses,
Vol. 13,
Issue. 5,
p.
924.
Meghdadi, Amir H.
Berka, Chris
Richard, Christian
Rupp, Greg
Smith, Stephanie
Stevanović Karić, Marija
McShea, Kevin
Sones, Emily
Marinković, Ksenija
and
Marcotte, Thomas
2021.
EEG event related potentials in sustained, focused and divided attention tasks: Potential biomarkers for cognitive impairment in HIV patients.
Clinical Neurophysiology,
Vol. 132,
Issue. 2,
p.
598.
McLaurin, Kristen A.
Harris, Michael
Madormo, Victor
Harrod, Steven B.
Mactutus, Charles F.
and
Booze, Rosemarie M.
2021.
HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits.
Cells,
Vol. 10,
Issue. 8,
p.
2158.